About: Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $434.24 (-4.21%)
MDGL NASDAQ Madrigal Pharmaceuticals Inc
Carregando status da lista de acompanhamento…
Madrigal Pharmaceuticals Inc share price
Atividade de preço de MDGL
Último preço
$ 434,240
Variação (24h)
-19,10 USD (4,21%)
Volume
234.83K
Volume (média 4 sem.)
-
Abertura
$ 453,55
Variação do dia
$ 433,31 - $ 453,55
Fechamento anterior
$ 453,34
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
MDGL price performance
-2,87%
5D
-15,36%
1M
-25,43%
YTD
+2,45%
1Y
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals